App News Today — November 14, 2026
Millions in US use unapproved GLP-1s—and use them in unapproved ways and more — today's app signal.
The intersection of technology and healthcare is a complex and rapidly evolving field, with new developments and challenges emerging daily. In the US, the use of GLP-1 medications is a prime example, with millions of people using these drugs in unapproved ways or not taking them as prescribed, highlighting the need for better education and adherence strategies. This issue is not only a concern for public health, but also for the pharmaceutical industry and regulatory bodies, as it raises questions about the efficacy and safety of these medications when used outside of approved guidelines.
Meanwhile, in the tech sector, innovations are being made to improve productivity and efficiency, such as the new app from ElevenLabs that combines meeting note-taking and dictation for teams, which has the potential to revolutionize the way we work and collaborate. Additionally, LinkAgent.com's audit of Link Meter and rejection of bot traffic demonstrates the importance of authenticity and accuracy in online interactions, a crucial aspect of the digital economy. As we move forward in this era of rapid technological advancement, it's essential to consider the implications of these developments on various aspects of our lives, from healthcare to productivity, and to strive for responsible and beneficial innovation that improves the human experience.
Today's signal:
• Millions in US use unapproved GLP-1s—and use them in unapproved ways (arstechnica.com)
• Millions of Americans are not taking their GLP-1 drugs as prescribed (arstechnica.com)
• LinkAgent.com Audits Link Meter, Rejects Bot Traffic (LinkAgent.com)
• ElevenLabs’ new app combines meeting note-taking and dictation for teams (techcrunch.com)